Event Has Raised More Than $4.6 Million over the Last Decade to Find a Cure for Duchenne Muscular Dystrophy NEWPORT BEACH, Calif., (July 19, 2022) – CureDuchenne, a leading global […]
Lianna Orlando, PhD and Bradley Hodges, PhD Bring Scientific and Investment Expertise to Global Rare Disease Nonprofit’s Venture Philanthropy Team Newport Beach, Calif. – May 13, 2022 – CureDuchenne, a […]
Premier Wine Series Brought Together Most Acclaimed Napa Valley Vintners Under One Roof in Philadelphia to Benefit Global Nonprofit CureDuchenne NEWPORT BEACH Calif., April 27, 2022 – CureDuchenne, a leading […]
Initiation of AFFINITY DUCHENNE™ trial of RGX-202 for the treatment of Duchenne will be delayed. This January, we shared the news that REGENXBIO received clearance from the U.S. FDA and would […]
Kent Mora and Nancy Young Bring Experience in Organizational Leadership and Strategic Fundraising to Rare Disease Nonprofit Newport Beach, Calif. – April 6, 2022 – CureDuchenne, a leading global nonprofit […]
We are pleased to share that Edgewise Therapeutics is sponsoring a natural history study in Becker muscular dystrophy, to better understand the course of disease and define endpoints to be […]
Registration Now Open for Three-Day National Conference in Orlando, Welcoming Attendees From Across the Globe Newport Beach, Calif. (March 25, 2022) – CureDuchenne, a leading global nonprofit focused on finding […]
The Event Brought the Austin Community Together for a Night of Fun with a Purpose Featuring Gourmet Food, Cocktails, Casino Games and More NEWPORT BEACH, Calif., April 6, 2022 – […]
CureDuchenne is happy to share the news that REGENXBIO will be launching a novel gene therapy trial in Duchenne during the first half of 2022. RGX-202 aims to deliver a […]
